EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic modulation of RNA splicing rescues BRCA2 function in mutant cells

Beatriz Anjo Lima, Ana Carolina Pais, Juliette Dupont iD, Patrícia Dias, Noélia Custódio iD, Ana Berta Sousa iD, Maria Carmo-Fonseca iD, Célia Carvalho iD

Life Science Alliance · 2025

DOI: 10.26508/lsa.202402845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Beatriz Anjo Lima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal. Hauptthemen laut MEDLINE: BRCA2 Protein, RNA Splicing, CRISPR-Cas Systems, Mutation. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEC | Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants in the hereditary cancer-associated BRCA1 and BRCA2 genes can alter RNA splicing, producing transcripts that encode internally truncated yet potentially functional proteins. However, few studies have quantitatively analyzed variant-specific splicing isoforms. Here, we investigated cells heterozygous and homozygous for the BRCA2 :c.681+5G>C variant. Using droplet digital RT–PCR, we identified two variant-specific mRNA isoforms. The predominant transcript is out-of-frame, contains a premature termination codon, and is degraded via the nonsense-mediated mRNA decay pathway. In addition, we detected a novel minor isoform encoding an internally truncated protein lacking non-essential domains. Homozygous mutant cells expressed low levels of BRCA2 protein and were defective in DNA repair. Using CRISPR-Cas9 gene editing, we induced the production of in-frame transcripts in mutant cells, which resulted in increased protein expression, enhanced RAD51 focus formation, and reduced chromosomal breaks after exposure to genotoxic agents. Our findings highlight the therapeutic potential of splicing modulation to restore BRCA2 function in mutant cells, offering a promising strategy to prevent cancer development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinRNA SplicingCRISPR-Cas SystemsMutationHumansGene EditingDNA RepairNonsense Mediated mRNA DecayRNA, MessengerCell Line, TumorFemaleBRCA1 ProteinRad51 RecombinaseBreast Neoplasms

Substanzen

BRCA2 ProteinBRCA2 protein, humanRNA, MessengerBRCA1 ProteinRad51 Recombinase

Autor:innen und Institutionen

  • Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.
  • Serviço de Genética, Unidade Local de Saúde Santa Maria, Centro Académico de Medicina de Lisboa, Lisboa, Portugal.
  • https://ror.org/0346k0491 GIMM - Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.
  • Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal carmo.fonseca@medicina.ulisboa.pt.
  • Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal celiacarv@edu.ulisboa.pt.

ORCID-Profile: Juliette Dupont, Noélia Custódio, Ana Berta Sousa, Maria Carmo-Fonseca, Célia Carvalho

Förderung

  • MEC | Fundação para a Ciência e a Tecnologia

Zitieren

APA

Lima, B. A., Pais, A. C., Dupont, J., Dias, P., Custódio, N., Sousa, A. B., Carmo-Fonseca, M., & Carvalho, C. (2025). Genetic modulation of RNA splicing rescues BRCA2 function in mutant cells. Life Science Alliance. https://doi.org/10.26508/lsa.202402845

Vancouver

Lima BA, Pais AC, Dupont J, Dias P, Custódio N, Sousa AB, et al. Genetic modulation of RNA splicing rescues BRCA2 function in mutant cells. Life Science Alliance. 2025. doi:10.26508/lsa.202402845

BibTeX
@article{Lima2025,
  author = {Lima, Beatriz Anjo and Pais, Ana Carolina and Dupont, Juliette and Dias, Patrícia and Custódio, Noélia and Sousa, Ana Berta and Carmo-Fonseca, Maria and Carvalho, Célia},
  title = {Genetic modulation of RNA splicing rescues BRCA2 function in mutant cells},
  journal = {Life Science Alliance},
  year = {2025},
  doi = {10.26508/lsa.202402845}
}
Kostenlos starten →